Log in to save to my catalogue

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1803079920

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

About this item

Full title

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2015-04, Vol.112 (16), p.5225-5230

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Significance Alzheimer’s disease (AD) is a devastating disease that results in the progressive cognitive deficits of elderly and has become one of major social and economic burdens worldwide. There is no effective drug or therapy to prevent or halt the progressive cognitive dysfunctions due to the complex mechanisms such as accumulation of amyloid-...

Alternative Titles

Full title

Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1803079920

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1803079920

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1422998112

How to access this item